Alliance Pharma PLC has received a major shareholding notification from Van Lanschot Kempen Investment Management NV. The notification, dated 23rd May 2024, indicates that Van Lanschot Kempen Investment Management NV now holds 9.900290% of the voting rights in Alliance Pharma PLC, representing a decrease from the previous position of 10.189070%. This change occurred on 21st May 2024.
The details of the notification show that Van Lanschot Kempen Investment Management NV holds 53,501,178 voting rights in Alliance Pharma PLC, with 4,995,118 direct voting rights and 48,506,060 indirect voting rights. The indirect voting rights represent 8.975950% and the direct voting rights represent 0.924340% of the total voting rights held.
The notification also confirms that Van Lanschot Kempen Investment Management NV does not control any other undertaking holding an interest in Alliance Pharma PLC, and it is not controlled by any natural person or legal entity.
This notification provides insight into the changes in the major shareholding of Alliance Pharma PLC and the details of the voting rights held by Van Lanschot Kempen Investment Management NV. It offers transparency regarding the ownership and control of voting rights within the company.
The notification was completed on 23rd May 2024 and supplied by Euroland.com. For further details, the full notification can be accessed on Euroland.com.